17389886

Source:http://linkedlifedata.com/resource/pubmed/id/17389886

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0020503, umls-concept:C0030520, umls-concept:C0178602, umls-concept:C0249582, umls-concept:C0301625, umls-concept:C2698651
pubmed:issue	4
pubmed:dateCreated	2007-3-28
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17389886-17183255
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101261800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents, http://linkedlifedata.com/resource/pubmed/chemical/Ergocalciferols, http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone, http://linkedlifedata.com/resource/pubmed/chemical/paricalcitol
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1745-8331
pubmed:author	pubmed-author:AghaiRachidR, pubmed-author:FournierAlbertA, pubmed-author:MailliezSébastienS, pubmed-author:MansourJeannetteJ, pubmed-author:ShahapuniIrinaI
pubmed:issnType	Electronic
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	E2; discussion E3
pubmed:meshHeading	pubmed-meshheading:17389886-Bone Density Conservation Agents, pubmed-meshheading:17389886-Dose-Response Relationship, Drug, pubmed-meshheading:17389886-Ergocalciferols, pubmed-meshheading:17389886-Humans, pubmed-meshheading:17389886-Hyperparathyroidism, Secondary, pubmed-meshheading:17389886-Parathyroid Hormone, pubmed-meshheading:17389886-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Optimal paricalcitol starting dose for parathyroid hormone suppression in secondary hyperparathyroidism.
pubmed:publicationType	Journal Article, Comment, Review